Analyzing Palisade Bio (NASDAQ:PALI) & Nexentis Technologies (NASDAQ:NXTS)

Palisade Bio (NASDAQ:PALI) and Nexentis Technologies (NASDAQ:NXTS) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, profitability, institutional ownership and earnings.

Insider & Institutional Ownership

11.8% of Palisade Bio shares are held by institutional investors. Comparatively, 61.2% of Nexentis Technologies shares are held by institutional investors. 0.1% of Palisade Bio shares are held by insiders. Comparatively, 6.5% of Nexentis Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent recommendations and price targets for Palisade Bio and Nexentis Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Palisade Bio	1	0	8	2	3.00
Nexentis Technologies	1	0	0	0	1.00

Palisade Bio currently has a consensus price target of $9.29, indicating a potential upside of 673.81%. Given Palisade Bio’s stronger consensus rating and higher possible upside, analysts clearly believe Palisade Bio is more favorable than Nexentis Technologies.

Earnings & Valuation

This table compares Palisade Bio and Nexentis Technologies”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Palisade Bio	$500,000.00	418.25	-$83.65 million	($0.48)	-2.50
Nexentis Technologies	N/A	N/A	N/A	($96.07)	-0.01

Nexentis Technologies has lower revenue, but higher earnings than Palisade Bio. Palisade Bio is trading at a lower price-to-earnings ratio than Nexentis Technologies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Palisade Bio and Nexentis Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Palisade Bio	N/A	N/A	N/A
Nexentis Technologies	N/A	N/A	N/A

Summary

Palisade Bio beats Nexentis Technologies on 6 of the 9 factors compared between the two stocks.

About Palisade Bio

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor, currently under pre-clinical development as a therapeutic for patients living with inflammatory bowel diseases, including ulcerative colitis and Crohn's disease (CD), as well as develops PALI-1908, an oral, selective PDE4 inhibitor prodrug that is locally bioactivated in the terminal ileum of CD patients, currently in the research stage. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California; a co-development and distribution agreement with Newsoara Biopharma Co., Ltd; and a transformative strategic collaboration with Strand Life Sciences for advancing precision medicine for ulcerative colitis therapy. The company is based in Carlsbad, California.

About Nexentis Technologies

N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. Its products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay. The company’s products include SavePROTECT or PeroStar, a processing aid for post-harvest application that is added to fruit and vegetable wash water; and SF3HS and SF3H, a post-harvest cleaning and sanitizing solution to control plant and foodborne pathogens. It also offers SpuDefender for controlling post-harvest potato sprouts; and FreshProtect to control spoilage-creating microorganisms on post-harvest citrus fruit. The company was formerly known as Save Foods, Inc. and changed its name to N2OFF, Inc. in March 2024. N2OFF, Inc. was incorporated in 2009 and is headquartered in Hod HaSharon, Israel.